Epirubicin

This classification denotes an anthracycline antibiotic with the molecular formula C27H29NO11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Z8479ZZ5X, chemically known as 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- but generally known as epirubicin, which bears US NIH Compound Identifier 41867. European Medicines Agency schedules Epirubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06571MIG. The term EPIRUBICIN is an International Non-Proprietary Name. World Health Organization schedules epirubicin in its Anatomical Therapeutic Chemical (ATC) Classification. EPIRUBICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule epirubicin under HS 29419000 and SITC 54139. As of Q4 2014, EPIRUBICIN remains the US FDA Preferred Term for this commodity. Epirubicin bears US NLM identifiers UMLS ID C0014582 and NCI Concept Code C62028. SMILES: O(C1CC(O)(CC2C1C(O)C1C(C2O)C(=O)C2C(C1=O)C(OC)CCC2)C(=O)CO)C1OC(C(O)C(N)C1)C.